These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31848493)

  • 21. Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort.
    Di Benedetto P; Cipriani P; Iacono D; Pantano I; Caso F; Emmi G; Grembiale RD; Cantatore FP; Atzeni F; Perosa F; Scarpa R; Guggino G; Ciccia F; Giacomelli R; Ruscitti P
    PLoS One; 2020; 15(7):e0235326. PubMed ID: 32645077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still's disease.
    Ruscitti P; Ursini F; Berardicurti O; Masedu F; Bozzalla Cassione E; Naldi S; Di Cola I; Di Muzio C; De Stefano L; Di Nino E; Navarini L; Vomero M; Bugatti S; Valenti M; Mariani E; Iagnocco A; Montecucco C; Giacomelli R; Cipriani P
    Rheumatology (Oxford); 2022 Dec; 62(1):321-329. PubMed ID: 35438139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between fever pattern and clinical manifestations of adult-onset Still's disease: unbiased analysis using hierarchical clustering.
    Kim MJ; Ahn EY; Hwang W; Lee Y; Lee EY; Lee EB; Song YW; Park JK
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):74-79. PubMed ID: 30582502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single center clinical analysis of macrophage activation syndrome complicating juvenile rheumatic diseases.
    Huang S; Liu Y; Yan W; Zhang T; Wang P; Zhu M; Zhang X; Zhou P; Fan Z; Yu H
    Pediatr Rheumatol Online J; 2024 May; 22(1):58. PubMed ID: 38783316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term, low-dose etoposide in refractory adult-onset Still's disease-associated macrophage activation syndrome.
    Wang R; Li T; Ye S; Lv L; Chen S; Wang X; Bao CD; Fu Q
    Clin Rheumatol; 2022 Sep; 41(9):2817-2823. PubMed ID: 35590113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elderly-onset Still's Disease Complicated by Macrophage Activation Syndrome: A Case Report and Review of the Literature.
    Suda T; Zoshima T; Takeji A; Suzuki Y; Mizushima I; Yamada K; Nakashima A; Yachie A; Kawano M
    Intern Med; 2020 Mar; 59(5):721-728. PubMed ID: 31708548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage activation syndrome complicating rheumatic diseases in adults: case-based review.
    Gilboa M; Bornstein G; Ben-Zvi I; Grossman C
    Rheumatol Int; 2020 Apr; 40(4):663-669. PubMed ID: 31367795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum β2-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset Still's disease.
    Wakabayashi K; Inokuma S; Matsubara E; Onishi K; Asashima H; Nakachi S; Hagiwara K
    Clin Rheumatol; 2013 Jul; 32(7):999-1005. PubMed ID: 23504210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine profiles of macrophage activation syndrome associated with rheumatic diseases.
    Maruyama J; Inokuma S
    J Rheumatol; 2010 May; 37(5):967-73. PubMed ID: 20231207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients.
    Ruscitti P; Rago C; Breda L; Cipriani P; Liakouli V; Berardicurti O; Carubbi F; Di Battista C; Verrotti A; Giacomelli R
    Clin Rheumatol; 2017 Dec; 36(12):2839-2845. PubMed ID: 28914368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The clinical characteristics of macrophage activation syndrome secondary to systemic lupus erythematosus].
    Jiang N; Li MT; Wu D; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2016 Nov; 55(11):840-844. PubMed ID: 27801337
    [No Abstract]   [Full Text] [Related]  

  • 32. Epidemiological study of adult-onset Still's disease using a Japanese administrative database.
    Sakata N; Shimizu S; Hirano F; Fushimi K
    Rheumatol Int; 2016 Oct; 36(10):1399-405. PubMed ID: 27502500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophage activation syndrome in neonates born to mothers with adult-onset Still's disease: Perinatal effect of maternal IL-18.
    Shimizu M; Kizawa T; Kato R; Suzuki T; Yachie A
    Clin Immunol; 2019 Oct; 207():36-39. PubMed ID: 31299380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-hospital mortality in febrile lupus patients based on 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome.
    Ahn SS; Yoo BW; Jung SM; Lee SW; Park YB; Song JJ
    Semin Arthritis Rheum; 2017 Oct; 47(2):216-221. PubMed ID: 28268026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.
    Chen DY; Chen YM; Lin CC; Hsieh CW; Wu YC; Hung WT; Chen HH; Lan JL
    BMC Musculoskelet Disord; 2015 May; 16():111. PubMed ID: 25956266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort.
    Kalyoncu U; Solmaz D; Emmungil H; Yazici A; Kasifoglu T; Kimyon G; Balkarli A; Bes C; Ozmen M; Alibaz-Oner F; Erten S; Cagatay Y; Cetin GY; Yilmaz S; Yildiz F; Pamuk ON; Kucuksahin O; Kilic L; Yazisiz V; Karadag O; Koca SS; Hayran M; Akar S; Aksu K; Akkoc N; Keser G; Gonullu E; Kisacik B; Onat AM; Soy M; Inanc N; Direskeneli H; Sayarlioglu M; Erken E; Turgay M; Cefle A; Ertenli I; Pay S
    J Autoimmun; 2016 May; 69():59-63. PubMed ID: 26970681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage activation syndrome associated with adult-onset Still's disease.
    Iwamoto M
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Dec; 30(6):428-31. PubMed ID: 18174671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum calprotectin as a marker for disease activity and severity in adult-onset Still's disease.
    Jung SY; Park YB; Ha YJ; Lee KH; Lee SK
    J Rheumatol; 2010 May; 37(5):1029-34. PubMed ID: 20231196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features of macrophage activation syndrome in the adult northern Chinese population.
    Li X; Qu B; Nie Y; Zhu G; Li W; Mu F
    Lupus; 2014 Jul; 23(8):785-92. PubMed ID: 24682586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients.
    Minoia F; Davì S; Horne A; Demirkaya E; Bovis F; Li C; Lehmberg K; Weitzman S; Insalaco A; Wouters C; Shenoi S; Espada G; Ozen S; Anton J; Khubchandani R; Russo R; Pal P; Kasapcopur O; Miettunen P; Maritsi D; Merino R; Shakoory B; Alessio M; Chasnyk V; Sanner H; Gao YJ; Huasong Z; Kitoh T; Avcin T; Fischbach M; Frosch M; Grom A; Huber A; Jelusic M; Sawhney S; Uziel Y; Ruperto N; Martini A; Cron RQ; Ravelli A; ; ; ;
    Arthritis Rheumatol; 2014 Nov; 66(11):3160-9. PubMed ID: 25077692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.